Peptide record

TPDB07526

Antibacterial Toxicity standard
14 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB07526
Antibacterial Toxicity
Anti-infective peptides Toxicity and safety peptides
AntiBP3 Peptipedia ToxinPred 3.0
standard
No
A 14-aa standard natural multi-activity (Antibacterial and Toxicity) peptide sequence curated from AntiBP3, Peptipedia, and ToxinPred 3.0, with an available 3D structural model.
Sequence
IKWKAILDAVKKVI
Physicochemical Analysis
C79H137N19O17
RNCEQGHMFPSTY
K
1625.07
10.55
4
1
9
+3
1.65
0.664
167.14
Mammalian: 20 hour Yeast: 30 min E.coli: >10 hour
5500
338.45
0
Residue Composition
number
2
A
0
R
0
N
1
D
0
C
0
E
0
Q
0
G
0
H
3
I
1
L
4
K
0
M
0
F
0
P
0
S
0
T
1
W
0
Y
2
V
Amino Acid Distribution
A: 2 R: 0 N: 0 D: 1 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 3 L: 1 K: 4 M: 0 F: 0 P: 0 S: 0 T: 0 W: 1 Y: 0 V: 2
Chemical Descriptors
14
C79H137N19O17
1625.07
10.55
+3
1.65
0.664
Evidence Records 18 records
Evidence 1 Activity

Activity

MIC
Antibacterial
32-64 µg/mL

Target

Staphylococcus aureus CCRC12652 or CCRC15211

Source & Reference

NA

Other

Active against Gram+ S. aureus CCRC12652 or CCRC15211 (MIC 32-64 ug/ml), S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 12 ug/ml), Gram- C. koseri (MIC 4 ug/ml)
Evidence 2 Activity

Activity

MIC
Antibacterial
2 µg/mL

Target

S. xylosus

Source & Reference

NA

Other

Active against Gram+ S. aureus CCRC12652 or CCRC15211 (MIC 32-64 ug/ml), S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 12 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Am
Evidence 3 Activity

Activity

MIC
Antibacterial
12 µg/mL

Target

S. alactolyticus

Source & Reference

NA

Other

ainst Gram+ S. aureus CCRC12652 or CCRC15211 (MIC 32-64 ug/ml), S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 12 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K. pneumoniae CC
Evidence 4 Activity

Activity

MIC
Antibacterial
4 µg/mL

Target

C. koseri

Source & Reference

NA

Other

15211 (MIC 32-64 ug/ml), S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 12 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K. pneumoniae CCRC10694 (MIC 32 ug/ml), S. Chol
Evidence 5 Activity

Activity

MIC
Antibacterial
8 µg/mL

Target

Escherichia coli BL21 or JM109 Amp

Source & Reference

NA

Other

S. xylosus (MIC 2 ug/ml), S. alactolyticus (MIC 12 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K. pneumoniae CCRC10694 (MIC 32 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium C
Evidence 6 Activity

Activity

MIC
Antibacterial
32 µg/mL

Target

Klebsiella pneumoniae CCRC10694

Source & Reference

NA

Other

s (MIC 12 ug/ml), Gram- C. koseri (MIC 4 ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K. pneumoniae CCRC10694 (MIC 32 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelyti
Evidence 7 Activity

Activity

MIC
Antibacterial
32 µg/mL

Target

S. Choleraesuis

Source & Reference

NA

Other

ug/ml), E. coli BL21 or JM109 Amp (MIC 8 ug/ml), K. pneumoniae CCRC10694 (MIC 32 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelytics CCRC10806 (MIC 16 ug/ml), and
Evidence 8 Activity

Activity

MIC
Antibacterial
32 µg/mL

Target

S. typhimurium CCRC12947

Source & Reference

NA

Other

mp (MIC 8 ug/ml), K. pneumoniae CCRC10694 (MIC 32 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelytics CCRC10806 (MIC 16 ug/ml), and P.aeruginosa (MIC 192 ug/ml).
Evidence 9 Activity

Activity

MIC
Antibacterial
16 µg/mL

Target

V. parahamelytics CCRC10806

Source & Reference

NA

Other

(MIC 32 ug/ml), S. Choleraesuis (MIC 32 ug/ml), S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelytics CCRC10806 (MIC 16 ug/ml), and P.aeruginosa (MIC 192 ug/ml).
Evidence 10 Activity

Activity

MIC
Antibacterial
192 µg/mL

Target

P.aeruginosa

Source & Reference

NA

Other

S. typhimurium CCRC12947 (MIC 32 ug/ml), V. parahamelytics CCRC10806 (MIC 16 ug/ml), and P.aeruginosa (MIC 192 ug/ml).
Evidence 11 Activity

Activity

4% Hemolysis
Toxicity
32 µg/mL
Hemolytic Cytotoxic
4% Hemolysis | 32 | µg/mL | target cell: Sheep erythrocytes

Target

Sheep erythrocytes

Source & Reference

NA
DBAASP
Structural and biological characterization of mastoparans in the venom of Vespa species in Taiwan. | Peptides | 2011
Evidence 12 Activity

Activity

8% Hemolysis
Toxicity
64 µg/mL
Hemolytic Cytotoxic
8% Hemolysis | 64 | µg/mL | target cell: Sheep erythrocytes

Target

Sheep erythrocytes

Source & Reference

NA
DBAASP
Structural and biological characterization of mastoparans in the venom of Vespa species in Taiwan. | Peptides | 2011
Evidence 13 Activity

Activity

17% Hemolysis
Toxicity
128 µg/mL
Hemolytic Cytotoxic
17% Hemolysis | 128 | µg/mL | target cell: Sheep erythrocytes

Target

Sheep erythrocytes

Source & Reference

NA
DBAASP
Structural and biological characterization of mastoparans in the venom of Vespa species in Taiwan. | Peptides | 2011
Evidence 14 Activity

Activity

27% Hemolysis
Toxicity
256 µg/mL
Hemolytic Cytotoxic
27% Hemolysis | 256 | µg/mL | target cell: Sheep erythrocytes

Target

Sheep erythrocytes

Source & Reference

NA
DBAASP
Structural and biological characterization of mastoparans in the venom of Vespa species in Taiwan. | Peptides | 2011
Evidence 15 Activity

Activity

0% Hemolysis
Toxicity
32 µg/mL
Hemolytic Cytotoxic
0% Hemolysis | 32 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Structural and biological characterization of mastoparans in the venom of Vespa species in Taiwan. | Peptides | 2011
Evidence 16 Activity

Activity

3% Hemolysis
Toxicity
64 µg/mL
Hemolytic Cytotoxic
3% Hemolysis | 64 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Structural and biological characterization of mastoparans in the venom of Vespa species in Taiwan. | Peptides | 2011
Evidence 17 Activity

Activity

14% Hemolysis
Toxicity
128 µg/mL
Hemolytic Cytotoxic
14% Hemolysis | 128 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Structural and biological characterization of mastoparans in the venom of Vespa species in Taiwan. | Peptides | 2011
Evidence 18 Activity

Activity

37% Hemolysis
Toxicity
256 µg/mL
Hemolytic Cytotoxic
37% Hemolysis | 256 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Structural and biological characterization of mastoparans in the venom of Vespa species in Taiwan. | Peptides | 2011